Aytu Biopharma, Inc Ratios

Ratios Aug2009 Aug2010 Aug2011 Aug2012 Aug2013 Jun2014 Jun2015 Jun2016 Jun2017 Jun2018 Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Profitability
Gross Margin 66.34%62.65%56.00%43.98%69.92%70.03%44.49%54.08%62.04%75.26%69.04%
EBT Margin -7,817.26%-3,410.00%-3,275.31%-10,847.61%-2,959.45%-1,099.73%-777.34%-558.72%-237.45%-49.29%-88.42%-112.64%-15.88%-15.92%-20.71%
EBIT Margin -7,635.37%-3,220.34%-2,995.09%-10,770.31%-2,915.53%-847.02%-624.70%-538.24%-230.13%-76.47%-89.70%-113.69%-15.89%-3.34%-11.79%
EBITDA Margin 3,434.74%3,400.29%25,783.49%-3,220.34%-2,995.09%-10,770.31%-2,915.53%-847.02%-624.70%-538.24%-230.13%-76.47%-89.70%-113.69%-15.89%-3.34%-11.79%
Operating Margin -7,635.37%-3,220.34%-2,995.09%-10,770.31%-2,915.53%-847.02%-624.70%-538.24%-230.13%-76.47%-89.70%-113.69%-15.89%-3.34%-11.79%
Net Margin -7,817.26%-3,410.00%-3,275.31%-9,466.80%-2,950.32%-1,099.73%-783.94%-558.72%-237.45%-49.29%-88.81%-112.53%-15.99%-5.10%0.93%
FCF Margin -3,703.89%-3,698.23%-3,689.94%-9,352.37%-2,534.25%-456.50%-452.56%-446.44%-195.77%-102.78%-43.18%-29.82%-4.78%-2.63%-3.26%
Efficiency
Inventory Average 0.28M0.92M1.33M1.39M5.72M13.17M13.59M11.42M12.07M11.79M
Assets Average 0.03M0.02M0.02M0.01M6.01M15.10M21.26M19.67M18.03M27.89M94.01M209.48M201.65M137.04M127.28M121.14M
Equity Average 3.51M1.76M-0.05M-0.09M2.63M10.49M12.85M7.04M8.71M10.26M51.05M116.29M90.94M41.83M33.54M23.34M
Invested Capital 3.52M3.62M0.02M-0.00M-0.01M5.52M15.62M10.09M4.26M13.97M8.17M95.22M153.85M59.31M40.92M30.11M28.03M
Asset Utilization Ratio 0.050.070.100.160.010.020.120.160.200.260.290.310.480.780.510.55
Leverage & Solvency
Interest Coverage Ratio -41.98-16.98-10.69-66.37-3.95-7.94-26.29-31.46-8.11-3.44-0.43-2.11
Debt to Equity 0.020.02-1.47-0.98-0.900.030.070.040.150.010.120.410.410.481.05
Debt Ratio 1.302.862.295.3810.290.010.020.030.030.010.060.130.120.110.16
Equity Ratio 82.90130.94-1.56-5.51-11.470.450.860.410.270.640.200.620.520.320.290.230.15
Times Interest Earned -41.98-16.98-10.69-66.37-3.95-7.94-26.29-31.46-8.11-3.44-0.43-2.11
Dividends & Payouts
FCF Payout Ratio 0.00
Valuation
Enterprise Value -0.01M-0.00M-0.00M-109.00-0.00M-2.64M-7.35M-9.10M-0.88M2.30M20.19M122.44M75.95M7.26M-16.94M-3.75M-17.50M
Market Capitalization 9.42M31.49M170.77M126.10M26.62M6.05M16.26M13.45M
Return Ratios
Return on Sales -78.17%-34.10%-32.75%-94.67%-29.50%-11.00%-7.84%-5.59%-2.37%-0.49%-0.89%-1.13%-0.16%-0.05%0.01%
Return on Capital Employed 3.99%0.87%0.48%79.94%-0.56%-1.94%-1.25%-1.35%-0.75%-0.32%-0.59%-0.80%-0.25%-0.03%-0.13%
Return on Invested Capital -2.01%-0.72%-1.03%
Return on Assets -5.48%-3.36%-5.14%-0.93%-0.51%-1.33%-1.28%-1.13%-0.62%-0.14%-0.28%-0.54%-0.13%-0.03%0.01%
Return on Equity -0.08%1.13%0.63%-2.12%-0.74%-2.19%-3.59%-2.35%-1.69%-0.27%-0.50%-1.20%-0.41%-0.10%0.03%